New Insights into DPCO, 2013 and NPPA Oversight
The DPCO, 2013, is a cornerstone in India’s pharmaceutical regulation, balancing the interests of manufacturers and consumers by ensuring fair drug pricing. Through annual revisions, strict GMP compliance, and vigilant monitoring, the NPPA ensures that medications remain affordable and accessible, reflecting the government’s commitment to public health.
New Initiatives to Revamp Urban Transport System
On July 29th, 2024, the Ministry of Housing & Urban Affairs (MoHUA) issued a notification detailing new steps to revamp the urban transport system in India. These steps aim to improve the sustainability, efficiency, and integration of urban transport infrastructure.
Tea Board Revises List of NABL Accredited Laboratories Under Integrated Assessment Scheme
The Tea Board has updated its list of laboratories approved under the Integrated Assessment Scheme. This list was last updated on July 3, 2024. The list identifies 42 laboratories across India that meet the Tea Board’s stringent quality standards.
India’s First Prototype Fast Breeder Reactor Gets Green Signal
A significant milestone has been achieved in India’s nuclear energy program with the Atomic Energy Regulatory Board (AERB) granting permission for the “first approach to criticality” of the 500 MWe Prototype Fast Breeder Reactor (PFBR) at Kalpakkam.
Relaxing Norms for Toxicity Studies in Drug Approval
The CDSCO aims to streamline the drug approval process without compromising safety. The New Drugs and Clinical Trials Rules, 2019 allow for the acceptance of preclinical toxicity data generated in other countries, provided the data is of high quality and meets specified standards.
